Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pediatric Brain Tumor × High-Intensity Interval Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 16 Polycystic Ovary Syndrome 7 Prostatic Neoplasms 5 Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Lung Neoplasms 2 Insulin Resistance 2 Fatigue 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1 Brain Neoplasms 1

Interventions

Carmustine 2 poly ICLC 1 dapagliflozin 1 Topotecan 1 High-Intensity Interval Training 1 Diet, Ketogenic 1 Cyclophosphamide 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740839 2026-02-24

HYPE

Dana-Farber Cancer Institute

Phase NA Recruiting

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡